Shares of Cardinal Health (CAH) have been strong performers lately, with the stock up 8.6% over the past month. The stock hit a new 52-week high of $127.08 in the previous session. Cardinal Health has ...
Leerink Partners analyst Michael Cherny has maintained their bullish stance on CAH stock, giving a Buy rating on January 15.Stay Ahead of the ...
The company said the new DC will support its at-Home Solutions business and improve the delivery of medical supplies to ...
Bank of America Securities analyst Allen Lutz maintained a Buy rating on Cardinal Health (CAH – Research Report) yesterday and set a price ...
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments – Pharmaceutical and ...